Previous close | 724.10 |
Open | 725.10 |
Bid | 0.00 x N/A |
Ask | 714.30 x N/A |
Day's range | 712.90 - 725.10 |
52-week range | 386.40 - 736.00 |
Volume | |
Avg. volume | 12 |
Market cap | 681.413B |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | 111.92 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.75 (0.66%) |
Ex-dividend date | 14 Feb 2024 |
1y target est | N/A |
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
The Danish pharmaceutical firm, Europe’s most valuable company, said sales of the weight-loss drug jumped 106% in the first quarter.
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and Company beats earnings expectations. Reported EPS is $2.58, expectations were $2.47. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode. […]